Your browser doesn't support javascript.
loading
Pharmacokinetic Assessment of Vancomycin Loading Dose in Critically Ill Patients.
Álvarez, Osvaldo; Plaza-Plaza, Jose Cristian; Ramirez, Manuel; Peralta, Alexis; Amador, Cristián A; Amador, Roberto.
  • Álvarez O; Intensive Care Unit, Hospital del Salvador, Santiago, Chile.
  • Plaza-Plaza JC; Faculty of Chemistry, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Ramirez M; Intensive Care Unit, Hospital del Salvador, Santiago, Chile.
  • Peralta A; Rheumatology Laboratory, Hospital del Salvador, Santiago, Chile.
  • Amador CA; Laboratory of Renal Physiopathology, Center of Biomedical Research, Universidad Autónoma de Chile, Santiago, Chile.
  • Amador R; Intensive Care Unit, Hospital del Salvador, Santiago, Chile ramador@uc.cl.
Article en En | MEDLINE | ID: mdl-28607023
The vancomycin loading dose (LD) of 25 to 30 mg/kg is a frequently practiced strategy to achieve effective concentrations from the first-treatment dose. However, considering only the body weight for dosing might be inadequate in critically ill patients due to pharmacokinetics changes. We sought to assess achieving optimal trough serum levels of vancomycin and AUC0-24/MIC in the first 24 h of treatment by using an LD based on population pharmacokinetic parameters of critically ill patients. We performed a concurrent cohort study over 22 months of patients with severe sepsis who received intravenous vancomycin. The patients were treated with three different strategies to initiate vancomycin: without an LD (group A), with an LD of 25 to 30 mg/kg (group B), and with an LD based on population pharmacokinetic parameters of the critically ill patient (group C). An optimal trough serum concentration was achieved in 5, 9, and 83% of patients in groups A, B, and C, respectively. The number of patients that reached optimal AUC0-24 was 2 of 18 (11%), 5 of 11 (46%), and 11 of 12 (92%) in groups A, B, and C, respectively. The statistical analysis for both parameters revealed significant differences in group C with respect to other groups. The administration of the LD calculated from population pharmacokinetic parameters from the beginning of therapy is a more efficient strategy to obtain adequate trough serum concentrations and AUC0-24/MIC in critical patients.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones Estafilocócicas / Vancomicina / Sepsis / Antibacterianos Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2017 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones Estafilocócicas / Vancomicina / Sepsis / Antibacterianos Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2017 Tipo del documento: Article